AGM/EGMJul 13, 2026, 08:47 AM
Liminatus Pharma AGM to vote on 1-for-50 reverse stock split
AI Summary
Liminatus Pharma, Inc. announced its 2026 Annual Meeting of Stockholders to be held on August 3, 2026. Stockholders will vote on the election of two directors, the ratification of WithumSmith+Brown, PC as the independent registered public accounting firm, and a proposal to authorize the Board to approve a reverse stock split of up to 1-for-50 shares. The reverse stock split is proposed to meet Nasdaq listing requirements. The Board recommends a "FOR" vote on all proposals.
Key Highlights
- Annual Meeting of Stockholders scheduled for August 3, 2026, at 10:30 a.m. Pacific time.
- Proposes election of Nicholas Fernandez and Dr. Ji Yeon Baek as directors for three-year terms.
- Seeks ratification of WithumSmith+Brown, PC as independent auditor for fiscal year 2026.
- Proposes authorization for a reverse stock split of up to 1-for-50 shares.
- Reverse stock split aims to meet minimum bid price and other Nasdaq listing requirements.
- Record date for voting is July 2, 2026.
- Valetudo Therapeutics LLC, holding 14.3% of shares, intends to vote "FOR" all proposals.
Price Impact
More from LIMN